William Hill PLC (LON:WMH) “Buy” Rating Reiterated at Deutsche Bank; Marrone Bio Innovations (MBII) Shorts Lowered By 0.41%

In an analyst report issued on Tuesday, 16 January, William Hill PLC (LON:WMH) stock had its “Buy” Rating maintained by stock research analysts at Deutsche Bank.

Marrone Bio Innovations Incorporated (NASDAQ:MBII) had a decrease of 0.41% in short interest. MBII’s SI was 1.52 million shares in January as released by FINRA. Its down 0.41% from 1.52M shares previously. With 90,200 avg volume, 17 days are for Marrone Bio Innovations Incorporated (NASDAQ:MBII)’s short sellers to cover MBII’s short positions. The SI to Marrone Bio Innovations Incorporated’s float is 7.67%. The stock decreased 0.79% or $0.01 during the last trading session, reaching $1.26. About 51,836 shares traded. Marrone Bio Innovations, Inc. (NASDAQ:MBII) has risen 94.03% since January 16, 2017 and is uptrending. It has outperformed by 77.33% the S&P500.

Among 3 analysts covering Marrone Bio Innovations (NASDAQ:MBII), 2 have Buy rating, 0 Sell and 1 Hold. Therefore 67% are positive. Marrone Bio Innovations has $3.50 highest and $100 lowest target. $3’s average target is 138.10% above currents $1.26 stock price. Marrone Bio Innovations had 6 analyst reports since August 11, 2015 according to SRatingsIntel. The company was maintained on Friday, September 15 by Piper Jaffray. The rating was downgraded by Zacks to “Buy” on Tuesday, August 11. On Friday, July 21 the stock rating was maintained by Piper Jaffray with “Hold”. The firm has “Buy” rating by H.C. Wainwright given on Tuesday, August 15. As per Monday, August 14, the company rating was maintained by Piper Jaffray. Rodman & Renshaw initiated Marrone Bio Innovations, Inc. (NASDAQ:MBII) on Wednesday, March 16 with “Buy” rating.

Investors sentiment decreased to 0.78 in 2017 Q3. Its down 0.08, from 0.86 in 2017Q2. It dropped, as 3 investors sold Marrone Bio Innovations, Inc. shares while 6 reduced holdings. 6 funds opened positions while 1 raised stakes. 11.77 million shares or 0.87% less from 11.88 million shares in 2017Q2 were reported. Raymond James Services Advisors holds 16,061 shares. Two Sigma Secs Limited Liability holds 11,088 shares or 0% of its portfolio. State Street has invested 0% in Marrone Bio Innovations, Inc. (NASDAQ:MBII). Ogorek Anthony Joseph Adv holds 0% of its portfolio in Marrone Bio Innovations, Inc. (NASDAQ:MBII) for 300 shares. Morgan Stanley owns 480 shares. 75,948 are held by Blackrock Incorporated. Vanguard Gru Incorporated has invested 0% in Marrone Bio Innovations, Inc. (NASDAQ:MBII). Ardsley Advisory Prtn reported 0.56% of its portfolio in Marrone Bio Innovations, Inc. (NASDAQ:MBII). Azimuth Cap Mgmt Ltd Llc has invested 0% of its portfolio in Marrone Bio Innovations, Inc. (NASDAQ:MBII). Virtu Financial Ltd Company holds 0% or 20,446 shares in its portfolio. Art Advsrs Lc invested in 0% or 23,171 shares. Geode Capital Management Limited Com accumulated 89,410 shares. Hanson Mcclain holds 0% of its portfolio in Marrone Bio Innovations, Inc. (NASDAQ:MBII) for 10,000 shares. Illinois-based Northern has invested 0% in Marrone Bio Innovations, Inc. (NASDAQ:MBII). Primecap Mgmt Ca has invested 0% in Marrone Bio Innovations, Inc. (NASDAQ:MBII).

Marrone Bio Innovations, Inc. provides bio pest management and plant health products primarily for agricultural and water markets in the United States and internationally. The company has market cap of $39.50 million. It offers herbicides; fungicides; nematicides; insecticides; algaecides for algae control; molluscicides for mussel and snail control; plant growth and stress regulators; and water treatment products for various applications, such as hydroelectric and thermoelectric power generation, industrial applications, drinking water, aquaculture, irrigation, and recreation. It currently has negative earnings. The companyÂ’s products include Regalia, a plant extract fungicidal biopesticide for plant disease control and plant health; and Grandevo, a bioinsecticide for insect and mite control to the growers of specialty crops, such as grapes, citrus, tomatoes, vegetables, nuts, leafy greens, and ornamental plants.

Among 26 analysts covering William Hill PLC (LON:WMH), 9 have Buy rating, 4 Sell and 13 Hold. Therefore 35% are positive. William Hill PLC has GBX 1750 highest and GBX 240 lowest target. GBX 324.70’s average target is -4.05% below currents GBX 338.4 stock price. William Hill PLC had 222 analyst reports since July 24, 2015 according to SRatingsIntel. The stock of William Hill plc (LON:WMH) earned “Hold” rating by Canaccord Genuity on Friday, April 22. The firm has “Hold” rating given on Monday, October 26 by Canaccord Genuity. On Wednesday, July 12 the stock rating was maintained by Peel Hunt with “Hold”. The company was maintained on Monday, September 7 by Citigroup. The rating was maintained by Numis Securities on Thursday, October 15 with “Buy”. The stock of William Hill plc (LON:WMH) has “Hold” rating given on Thursday, January 14 by Panmure Gordon. Deutsche Bank maintained William Hill plc (LON:WMH) rating on Friday, August 19. Deutsche Bank has “Buy” rating and GBX 390 target. The firm has “Hold” rating given on Friday, March 4 by Liberum Capital. Deutsche Bank maintained William Hill plc (LON:WMH) on Thursday, December 15 with “Buy” rating. The firm has “Buy” rating given on Monday, February 22 by Nomura.

William Hill PLC provides sports betting and gaming services in the United Kingdom, Australia, the United States, Italy, Spain, and internationally. The company has market cap of 2.90 billion GBP. It operates through Retail, Online, US, Australia, and Other divisions. It has a 18.1 P/E ratio. The firm operates licensed betting offices that offer various betting and gaming services, including horseracing, greyhound racing, football betting, virtual racing, numbers betting, and other services.

The stock increased 1.01% or GBX 3.4 during the last trading session, reaching GBX 338.4. About 725,947 shares traded. William Hill plc (LON:WMH) has 0.00% since January 16, 2017 and is . It has underperformed by 16.70% the S&P500.